Gadi Rennert - Epidemiology

Author Information

Gad Rennert is a distinguished epidemiologist affiliated with the Department of Community Medicine and Epidemiology at Carmel Medical Center and the B. Rappaport Faculty of Medicine at Technion-Israel Institute of Technology in Haifa, Israel. He is also associated with the Clalit Health Services National Cancer Control Center (NICCC) in Haifa, Israel. His work primarily focuses on cancer epidemiology, genetic epidemiology, and the application of artificial intelligence in medical research.

Research Contributions

Gad Rennert has made significant contributions to the field of epidemiology, particularly in cancer research. In 2022 alone, he published multiple papers that address critical topics such as the accuracy of imputed genotypes, the application of artificial intelligence in colorectal cancer detection, gene-environment interactions in breast cancer, and the role of genetic variants in cancer susceptibility. His research is widely recognized for its impact on understanding complex genetic and environmental factors influencing cancer risk and progression.

Aliases

Gad Rennert is also known by several aliases in academic publications, including G Rennert, G. Rennert, and Gadi Rennert.

Publication and Citation Metrics

Metric	Value
Total Papers	516
Total Citation Count	22,160
h-index	77

Publications:

Iam hiQ—a novel pair of accuracy indices for imputed genotypes

DOI: 10.1186/s12859-022-04568-3

Year: 2022

Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical application.

DOI: 10.1016/j.esmoop.2022.100400

Year: 2022

A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women

DOI: 10.1158/2767-9764.crc-21-0119

Year: 2022

Rare germline copy number variants (CNVs) and breast cancer risk

DOI: 10.1038/s42003-021-02990-6

Year: 2022

Forecasting chronic diseases in Africans – Evidence from an immigrant population cohort experience

DOI: 10.5430/jer.v8n1p1

Year: 2022

Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region.

DOI: 10.1158/1055-9965.EPI-21-1003

Year: 2022

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

DOI: 10.1186/s13058-021-01484-x

Year: 2022

Abstract P3-13-07: A comprehensive germline genetic landscape in young Jewish & Arab women with breast cancer

DOI: 10.1158/1538-7445.sabcs21-p3-13-07

Year: 2022

Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real‐Life: Retrospective Cohort Study

DOI: 10.1002/cpt.2552

Year: 2022

Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer

DOI: 10.1186/s40001-022-00638-7

Year: 2022

What are the Success Stories of FCTC Implementation?

What is the Future of mHealth Devices in Epidemiology?

What are Some Examples of Chemoprophylaxis Programs?

What are the Indicators of a Bioterrorism Event?

What is Multiplex Immunohistochemistry (mIHC)?

Why is Test Quality Important?

How are Effective Awareness Campaigns Designed?

How is Dietary Data Collected in Epidemiological Studies?

How Can Data Transparency be Improved in Epidemiology?

How Does Quality Control Impact Laboratory Analysis?

Partnered Content Networks

Relevant Topics